Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



The Medicines Company Licenses Alnylam's Cholesterol Program

The Medicines Company (NASDAQ: MDCO  ) has licensed Alnylam Pharmaceuticals' (NASDAQ: ALNY  ) cholesterol-lowering ALN-PCS RNAi therapeutic program, the companies announced today. Alnylam is due $25 million upfront from The Medicines Company, and Alnylam could receive up to an additional $180 million if development and commercial milestones are met. If a drug from the program makes it to market, Alnylam will be eligible to receive scaled double-digit royalties on global products sales.

The ALN-PCS program targets proprotein convertase subtilisin/kexin type 9, or PCSK9, a protein that regulates the low-density lipoprotein receptors that remove the bad LDL cholesterol from the blood. Knocking down the level of PCSK9 with RNAi increases the activity of the receptor, which reduces cholesterol levels.

The program includes ALN-PCS02, which is delivered intravenously, and ALN-PCSsc, which can be injected subcutaneously under the skin. ALN-PCS02 has already completed a phase 1 trial in healthy volunteers that demonstrated the potential to lower LDL cholesterol levels by 50% after just one injection. The subcutaneous version is still in pre-clinical development.

Anlylam will advance the program through phase 1 trials, after which The Medicines Company will take over development and commercialize the drugs if they make it to market.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2234310, ~/Articles/ArticleHandler.aspx, 9/25/2016 1:48:31 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 18,261.45 -131.01 -0.71%
S&P 500 2,164.69 -12.49 -0.57%
NASD 5,305.75 -33.78 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/23/2016 4:00 PM
ALNY $75.57 Down -1.52 -1.97%
Alnylam Pharmaceut… CAPS Rating: ****
MDCO $40.45 Down -1.05 -2.53%
The Medicines Comp… CAPS Rating: ***